Kinetics of Antiviral Activity and Intracellular Pharmacokinetics of Human Immunodeficiency Virus Type 1 Protease Inhibitors in Tissue Culture

Ítems similars

• Intracellular Accumulation of Human Immunodeficiency Virus Protease Inhibitors
  per: Khoo, Saye H., et al.
  Publicat: (2002)
• Constrained Evolution of Human Immunodeficiency Virus Type 1 Protease during Sequential Therapy with Two Distinct Protease Inhibitors
  per: Dulioust, Anne, et al.
  Publicat: (1999)
• Amprenavir Inhibitory Quotient and Virological Response in Human Immunodeficiency Virus-Infected Patients on an Amprenavir-Containing Salvage Regimen without or with Ritonavir
  per: Duval, Xavier, et al.
  Publicat: (2002)
• Genotypic Inhibitory Quotient as Predictor of Virological Response to Ritonavir-Amprenavir in Human Immunodeficiency Virus Type 1 Protease Inhibitor-Experienced Patients
  per: Marcelin, Anne-Geneviève, et al.
  Publicat: (2003)
• Intracellular Antiviral Activity of Low-Dose Ritonavir in Boosted Protease Inhibitor Regimens
  per: De Nicolò, Amedeo, et al.
  Publicat: (2014)